ANTIXAN® edaravone is approved by ANMAT for the following indications:

  • Inhibition in the progression of functional disorders in patients with Amyotrophic Lateral Seclerosis (ALS)
  • Improve neurological symptoms, disorders in daily activities.

PRESENTATION:

  • 30 mg x 10 injection

Bioprofarma Bagó
Trabajando el presente, pensando el futuro.

Noticias relacionadas